Author

John Babich

OpenAlex ID: A5137203347

The ATLAS study: A first-in-human phase 1/2 trial of [Ac-225]RTX-2358 in patients with relapsed or refractory soft tissue sarcoma.

2026 · Sandra P. D'Angelo, William D. Tap, et al. · Journal of Clinical Oncology · 1

Works count: 1

Citation count: 1

H-index: 1

I10-index: